Alivus Life Sciences shareholding pattern

ALIVUS

HealthcareLarge

1064.9

3.90 (-0.36%)
Last updated on 18 Jul, 2025 | 09:48 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Alivus Life Sciences Shareholding Pattern

  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
Total Promoters
Segment
Percent

Total Promoters

74.99%

Mutual Fund

3.59%

Insurance

0.22%

Foreign Institutional Investors

6.57%

Domestic Institutional Investors

1.38%

Retail

13.25%

Others

0%

Total Promoters
MAR '25
74.99%

Alivus Life Sciences FAQs

As of 07-2025, the promoter shareholding in Alivus Life Sciences stands at 74.99% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of Alivus Life Sciences is 6.57% and 1.38% respectively.

The retail shareholding of the Alivus Life Sciences is 13.25%.

Changes in shareholding patterns of Alivus Life Sciences can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of Alivus Life Sciences are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.